证券记录 · 已归档季度
HOLX
Hologic, Inc. · Healthcare · Medical - Instruments & Supplies
21被追踪持有人
+4Δ持有人
78.04M持有股份
$5.08B报告持仓市值
+4新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +23.5% ·
股份流向 +9.4% ·
净新建仓位 +19.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q1 2026 | 150 | -11 | 142.41M | $10.76B | n/a | −12 |
| Q4 2025 | 160 | -1 | 162.64M | $12.11B | +3 | −3 |
| Q3 2025 | 23 | 0 | 82.82M | $5.59B | +1 | −2 |
| Q2 2025 | 21 | +4 | 78.04M | $5.08B | +4 | n/a |
| Q1 2025 | 14 | -1 | 24.06M | $1.49B | n/a | −1 |
| Q4 2024 | 15 | 0 | 25.76M | $1.86B | n/a | n/a |
| Q3 2024 | 14 | -1 | 17.19M | $1.40B | n/a | −1 |
| Q2 2024 | 15 | n/a | 21.25M | $1.58B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 26.80M | n/a | $1.75B | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 2 | BlackRock ✦ (被动) | 19.94M | n/a | $1.30B | 0.0% | n/c | 1 | SEC ↗ ×21 |
| 3 | State Street Global Advisors ✦ (被动) | 10.10M | -0.1% | $658.04M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 5.83M | +1.7% | $378.21M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Citadel Advisors ✦ | 3.71M | +1342.2% | $241.67M | 0.2% | ▲ Add | 5 | SEC ↗ ×2 |
| 6 | Arrowstreet Capital ✦ | 2.77M | +28.1% | $180.35M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 7 | Norges Bank ✦ (被动) | 2.76M | +65.5% | $180.05M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 1.21M | -33.8% | $79.06M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 9 | Millennium Management ✦ | 968.76K | +397.6% | $63.12M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 740.99K | 新增 | $48.28M | 0.1% | New | 1 | SEC ↗ |
| 11 | D. E. Shaw & Co. ✦ | 725.08K | +24.6% | $47.25M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 532.15K | n/a | $34.67M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 13 | AQR Capital Management ✦ | 427.80K | -4.5% | $27.81M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 14 | Gotham Asset Management ✦ | 367.44K | +115.4% | $23.94M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 15 | Wellington Management ✦ | 364.62K | -25.9% | $23.76M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 16 | T. Rowe Price ✦ | 350.13K | -6.2% | $22.82M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 17 | Marshall Wace ✦ | 317.28K | 新增 | $20.67M | 0.0% | New | 1 | SEC ↗ ×2 |
| 18 | Two Sigma Investments ✦ | 68.30K | 新增 | $4.45M | 0.0% | New | 1 | SEC ↗ |
| 19 | Soros Fund Management ✦ | 39.14K | 新增 | $2.55M | 0.1% | New | 1 | SEC ↗ |
| 20 | Bridgewater Associates ✦ | 7.31K | -77.0% | $476,580 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 6.76K | +0.1% | $440,361 | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Adage Capital Partners | $48.28M | 0.1% |
| Marshall Wace | $20.67M | 0.0% |
| Two Sigma Investments | $4.45M | 0.0% |
| Soros Fund Management | $2.55M | 0.1% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 699 持有人, 212.67M 股份, $15.33B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据